Annual D&A
$5.55 M
+$3.53 M+174.04%
December 31, 2023
Summary
- As of February 26, 2025, ACAD annual depreciation & amortization is $5.55 million, with the most recent change of +$3.53 million (+174.04%) on December 31, 2023.
- During the last 3 years, ACAD annual D&A has risen by +$2.62 million (+89.36%).
- ACAD annual D&A is now at all-time high.
Performance
ACAD Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.57 M
-$1000.00-0.04%
September 30, 2024
Summary
- As of February 26, 2025, ACAD quarterly depreciation & amortization is $2.57 million, with the most recent change of -$1000.00 (-0.04%) on September 30, 2024.
- Over the past year, ACAD quarterly D&A has increased by +$847.00 thousand (+49.16%).
- ACAD quarterly D&A is now -53.51% below its all-time high of $5.53 million, reached on March 31, 2024.
Performance
ACAD Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$12.31 M
+$847.00 K+7.39%
September 30, 2024
Summary
- As of February 26, 2025, ACAD TTM depreciation & amortization is $12.31 million, with the most recent change of +$847.00 thousand (+7.39%) on September 30, 2024.
- Over the past year, ACAD TTM D&A has increased by +$7.90 million (+179.43%).
- ACAD TTM D&A is now at all-time high.
Performance
ACAD TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ACAD Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +174.0% | +49.2% | +179.4% |
3 y3 years | +89.4% | +160.9% | +237.4% |
5 y5 years | +84.8% | +294.8% | +344.9% |
ACAD Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +174.0% | -53.5% | +503.3% | at high | +535.6% |
5 y | 5-year | at high | +174.0% | -53.5% | +503.3% | at high | +535.6% |
alltime | all time | at high | +3902.7% | -53.5% | +443.1% | at high | +1797.4% |
ACADIA Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $2.57 M(-0.0%) | $12.31 M(+7.4%) |
Jun 2024 | - | $2.57 M(-53.5%) | $11.46 M(+7.6%) |
Mar 2024 | - | $5.53 M(+237.7%) | $10.65 M(+91.9%) |
Dec 2023 | $5.55 M(+174.0%) | $1.64 M(-5.0%) | $5.55 M(+26.1%) |
Sep 2023 | - | $1.72 M(-2.4%) | $4.40 M(+38.2%) |
Jun 2023 | - | $1.77 M(+314.6%) | $3.19 M(+64.6%) |
Mar 2023 | - | $426.00 K(-12.9%) | $1.94 M(-4.4%) |
Dec 2022 | $2.03 M(-39.4%) | $489.00 K(-3.4%) | $2.03 M(-2.2%) |
Sep 2022 | - | $506.00 K(-1.7%) | $2.07 M(-18.8%) |
Jun 2022 | - | $515.00 K(-0.2%) | $2.55 M(-14.0%) |
Mar 2022 | - | $516.00 K(-3.6%) | $2.96 M(-11.3%) |
Dec 2021 | $3.34 M(+14.1%) | $535.00 K(-45.7%) | $3.34 M(-8.3%) |
Sep 2021 | - | $985.00 K(+6.0%) | $3.65 M(+8.3%) |
Jun 2021 | - | $929.00 K(+3.8%) | $3.37 M(+6.5%) |
Mar 2021 | - | $895.00 K(+6.8%) | $3.16 M(+7.9%) |
Dec 2020 | $2.93 M(+6.0%) | $838.00 K(+18.5%) | $2.93 M(+7.4%) |
Sep 2020 | - | $707.00 K(-2.2%) | $2.73 M(+2.1%) |
Jun 2020 | - | $723.00 K(+8.9%) | $2.67 M(+1.1%) |
Mar 2020 | - | $664.00 K(+4.6%) | $2.65 M(-4.4%) |
Dec 2019 | $2.77 M(-8.0%) | $635.00 K(-2.5%) | $2.77 M(-5.0%) |
Sep 2019 | - | $651.00 K(-6.3%) | $2.91 M(-3.3%) |
Jun 2019 | - | $695.00 K(-11.5%) | $3.01 M(-0.5%) |
Mar 2019 | - | $785.00 K(+0.4%) | $3.03 M(+0.8%) |
Dec 2018 | $3.00 M(+10.8%) | $782.00 K(+4.1%) | $3.00 M(+2.8%) |
Sep 2018 | - | $751.00 K(+5.6%) | $2.92 M(+1.9%) |
Jun 2018 | - | $711.00 K(-6.6%) | $2.87 M(+1.2%) |
Mar 2018 | - | $761.00 K(+8.6%) | $2.83 M(+4.5%) |
Dec 2017 | $2.71 M(+48.4%) | $701.00 K(+0.6%) | $2.71 M(+2.7%) |
Sep 2017 | - | $697.00 K(+3.1%) | $2.64 M(+3.4%) |
Jun 2017 | - | $676.00 K(+5.8%) | $2.56 M(+9.7%) |
Mar 2017 | - | $639.00 K(+1.4%) | $2.33 M(+27.4%) |
Dec 2016 | $1.83 M(+182.5%) | $630.00 K(+3.3%) | $1.83 M(+37.9%) |
Sep 2016 | - | $610.00 K(+35.6%) | $1.33 M(+59.2%) |
Jun 2016 | - | $450.00 K(+226.1%) | $833.00 K(+25.6%) |
Mar 2016 | - | $138.00 K(+7.8%) | $663.00 K(+2.5%) |
Dec 2015 | $647.00 K(+214.1%) | $128.00 K(+9.4%) | $647.00 K(+11.6%) |
Sep 2015 | - | $117.00 K(-58.2%) | $580.00 K(+10.9%) |
Jun 2015 | - | $280.00 K(+129.5%) | $523.00 K(+83.5%) |
Mar 2015 | - | $122.00 K(+100.0%) | $285.00 K(+38.3%) |
Dec 2014 | $206.00 K | $61.00 K(+1.7%) | $206.00 K(+12.0%) |
Sep 2014 | - | $60.00 K(+42.9%) | $184.00 K(+31.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2014 | - | $42.00 K(-2.3%) | $140.00 K(+27.3%) |
Mar 2014 | - | $43.00 K(+10.3%) | $110.00 K(+39.2%) |
Dec 2013 | $79.00 K(-27.5%) | $39.00 K(+143.8%) | $79.00 K(+29.5%) |
Sep 2013 | - | $16.00 K(+33.3%) | $61.00 K(-54.1%) |
Jun 2013 | - | $12.00 K(0.0%) | $133.00 K(+9.9%) |
Mar 2013 | - | $12.00 K(-42.9%) | $121.00 K(+11.0%) |
Dec 2012 | $109.00 K(-61.8%) | $21.00 K(-76.1%) | $109.00 K(-7.6%) |
Sep 2012 | - | $88.00 K(+193.3%) | $118.00 K(-58.6%) |
Dec 2011 | $285.00 K(-53.0%) | $30.00 K(0.0%) | $285.00 K(-36.5%) |
Sep 2011 | - | $30.00 K(-16.7%) | $449.00 K(-13.7%) |
Jun 2011 | - | $36.00 K(-81.0%) | $520.00 K(-16.4%) |
Mar 2011 | - | $189.00 K(-2.6%) | $622.00 K(+2.5%) |
Dec 2010 | $607.00 K(-45.4%) | $194.00 K(+92.1%) | $607.00 K(-29.2%) |
Sep 2010 | - | $101.00 K(-26.8%) | $857.00 K(-12.1%) |
Jun 2010 | - | $138.00 K(-20.7%) | $975.00 K(-8.0%) |
Mar 2010 | - | $174.00 K(-60.8%) | $1.06 M(-4.6%) |
Dec 2009 | $1.11 M(+6.5%) | $444.00 K(+102.7%) | $1.11 M(+340.9%) |
Sep 2009 | - | $219.00 K(-1.8%) | $252.00 K(-69.0%) |
Jun 2009 | - | $223.00 K(-0.9%) | $813.00 K(-26.4%) |
Mar 2009 | - | $225.00 K(-154.2%) | $1.10 M(+5.9%) |
Dec 2008 | $1.04 M(+35.8%) | -$415.00 K(-153.2%) | $1.04 M(-52.6%) |
Sep 2008 | - | $780.00 K(+51.5%) | $2.20 M(+55.0%) |
Jun 2008 | - | $515.00 K(+216.0%) | $1.42 M(+170.2%) |
Mar 2008 | - | $163.00 K(-78.1%) | $526.00 K(-31.5%) |
Dec 2007 | $768.00 K(-626.0%) | $744.00 K(<-9900.0%) | $768.00 K(-205.9%) |
Sep 2007 | - | -$1000.00(-99.7%) | -$725.00 K(+43.6%) |
Jun 2007 | - | -$380.00 K(-193.8%) | -$505.00 K(-821.4%) |
Mar 2007 | - | $405.00 K(-154.1%) | $70.00 K(-147.9%) |
Dec 2006 | -$146.00 K(-114.2%) | -$749.00 K(-442.0%) | -$146.00 K(-118.0%) |
Sep 2006 | - | $219.00 K(+12.3%) | $810.00 K(-0.1%) |
Jun 2006 | - | $195.00 K(+3.2%) | $811.00 K(-10.8%) |
Mar 2006 | - | $189.00 K(-8.7%) | $909.00 K(-11.4%) |
Dec 2005 | $1.03 M(-21.4%) | $207.00 K(-5.9%) | $1.03 M(-12.8%) |
Sep 2005 | - | $220.00 K(-24.9%) | $1.18 M(-6.8%) |
Jun 2005 | - | $293.00 K(-4.2%) | $1.26 M(-1.2%) |
Mar 2005 | - | $306.00 K(-14.5%) | $1.28 M(-2.2%) |
Dec 2004 | $1.31 M(-2.8%) | $357.70 K(+17.2%) | $1.31 M(+37.7%) |
Sep 2004 | - | $305.30 K(-1.0%) | $948.30 K(+47.5%) |
Jun 2004 | - | $308.40 K(-7.8%) | $643.00 K(+92.2%) |
Mar 2004 | - | $334.60 K | $334.60 K |
Dec 2003 | $1.34 M(-4.2%) | - | - |
Dec 2002 | $1.40 M | - | - |
FAQ
- What is ACADIA Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual D&A year-on-year change?
- What is ACADIA Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly D&A year-on-year change?
- What is ACADIA Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals TTM D&A year-on-year change?
What is ACADIA Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ACAD is $5.55 M
What is the all time high annual D&A for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual depreciation & amortization is $5.55 M
What is ACADIA Pharmaceuticals annual D&A year-on-year change?
Over the past year, ACAD annual depreciation & amortization has changed by +$3.53 M (+174.04%)
What is ACADIA Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ACAD is $2.57 M
What is the all time high quarterly D&A for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly depreciation & amortization is $5.53 M
What is ACADIA Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ACAD quarterly depreciation & amortization has changed by +$847.00 K (+49.16%)
What is ACADIA Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ACAD is $12.31 M
What is the all time high TTM D&A for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high TTM depreciation & amortization is $12.31 M
What is ACADIA Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ACAD TTM depreciation & amortization has changed by +$7.90 M (+179.43%)